Nu Skin Enterprises (NYSE:NUS – Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results after the market closes on Thursday, May 8th. Analysts expect Nu Skin Enterprises to post earnings of $0.13 per share for the quarter. Nu Skin Enterprises has set its Q1 2025 guidance at 0.100-0.200 EPS and its FY 2025 guidance at 0.900-1.300 EPS.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to analysts’ expectations of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Price Performance
NUS stock opened at $5.80 on Wednesday. Nu Skin Enterprises has a one year low of $5.32 and a one year high of $14.00. The firm has a 50-day moving average of $6.82 and a two-hundred day moving average of $6.94. The firm has a market capitalization of $288.14 million, a PE ratio of -1.96 and a beta of 0.92. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56.
Nu Skin Enterprises Announces Dividend
Analyst Upgrades and Downgrades
Separately, StockNews.com cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Tuesday, April 8th.
View Our Latest Stock Report on Nu Skin Enterprises
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- The 3 Best Retail Stocks to Shop for in August
- 3 Mid-Cap Medical Stocks Outperforming the Market
- When to Sell a Stock for Profit or Loss
- The Top-Ranked Insider Buys From April by Market Cap
- What Are the FAANG Stocks and Are They Good Investments?
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.